PE-22-28 (10mg)

PE-22-28 (10mg): Product Description

PE‑22‑28 is a synthetic short-chain peptide investigated in controlled laboratory models involving neurotrophic signaling and neuroplasticity-associated cellular mechanisms. It was developed as a peptide analog associated with the activity of spadin, a naturally derived peptide studied for its interaction with TREK‑1 potassium channels.

Experimental research involving PE‑22‑28 may examine TREK‑1 channel modulation, neuronal excitability, neurogenesis-associated signaling, synaptic plasticity and cellular pathways related to mood and cognitive processing. Researchers may also use the compound to investigate how short peptide structures interact with ion-channel systems and influence downstream cellular communication.

PE‑22‑28 should be represented strictly as an investigational laboratory reagent. References to mood, cognition or neurogenesis describe areas of experimental study and do not establish therapeutic effects or suitability for human use. Outcomes can vary according to cell type, assay design, concentration, chemical preparation and the specific peptide sequence supplied.

the 10 mg presentation exclusively for in-vitro laboratory research. Identity, sequence, purity and exact molecular characteristics should be confirmed using its batch-specific Certificate of Analysis.

Research Specifications

Molecular Formula: C35H55N11O9

Molecular Weight: Approximately 773.88 g/mol

CAS Number: Commonly listed as 1801959-12-5

Compound Type: Synthetic short-chain research peptide

Presentation: 10 mg

Research Areas: TREK‑1, neurotrophic signaling and neuroplasticity models

Purity: ≥99% by HPLC

For Research Use Only. Not for human or animal consumption. Not intended for diagnostic or therapeutic use.